Contracts › W91YTZ21C0012
W91YTZ21C0012: New - Std Pathogens Molecular Testing Reageants
Awarded to Cepheid by Department of the Army.
$3.1Mobligated
$3.1Mpotential value
30 September 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | W91YTZ21C0012 |
|---|---|
| Awardee | Cepheid |
| Awarding agency | Department of the Army |
| Awarding office | W40M USA HCA |
| NAICS | 325413 In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6640 Laboratory Equipment and Supplies |
| Place of performance | NC |
| Offers received | 1 |
| Period of performance | 01 October 2021 to 30 September 2026 |
| Potential end | 30 September 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325413 contracts · All expiring contracts · USASpending record